Search Results
Herceptin—a targeted antibody therapy for breast cancer
Herceptin - the first monoclonal treatment for cancer
Herceptin (trastuzumab) for HER2-Positive Breast and Stomach Cancer
How Monoclonal Antibodies Treat Cancer
Study of Targeted Therapy for HER2-Positive Metastatic Breast Cancer
HER2-Targeted Therapies
Trastuzumab (Herceptin) and Pertuzumab (Perjeta) for Breast Cancer: What You Need to Know
Clinical usage of antibody: Herceptin (Antibody as breast cancer medicine)
TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal
Susan Desmond-Hellmann (UCSF): Herceptin and Drug Development
Trastuzumab Deruxtecan for Breast Cancer | NEJM
Current Treatment Options for Patients With HER2-Positive Metastatic Breast Cancer
